0.780
-0.15 (-16.16%)
| Previous Close | 0.930 |
| Volume | 4,757,113 |
| Price / Sales | 2.98 |
| Price / Book | 0.750 |
| 52 Weeks Range |
| Operating Margin (TTM) | -500.53% |
| Diluted EPS (TTM) | -0.910 |
| Quarterly Revenue Growth (YOY) | 10.30% |
| Total Debt/Equity (MRQ) | 4.18% |
| Current Ratio (MRQ) | 5.30 |
| Operating Cash Flow (TTM) | -37.48 M |
| Levered Free Cash Flow (TTM) | -20.36 M |
| Return on Assets (TTM) | -17.89% |
| Return on Equity (TTM) | -30.11% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | NANO-X IMAGING LTD | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 2.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.25 |
|
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 0.23% |
| % Held by Institutions | 24.70% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MELTZER EREZ | 0.730 | - | 10,000 | 7,300 |
| SUESSKIND DAN S | 0.700 | - | 60,000 | 42,000 |
| Aggregate Net Quantity | 70,000 | |||
| Aggregate Net Value ($) | 49,300 | |||
| Aggregate Avg. Buy ($) | 0.715 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SUESSKIND DAN S | Director | 14 Sep 2026 | Buy (+) | 60,000 | 0.700 | 42,000 |
| MELTZER EREZ | Officer | 10 Sep 2026 | Buy (+) | 10,000 | 0.730 | 7,300 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |